Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Osborne

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Health Affairs (Project Hope)|May 7, 2019
The Culture Of Health In Early Care And Education: Workers' Wages, Health, And Job CharacteristicsJennifer J Otten, Victoria A Bradford, Bert Stover, et al.
The New England Journal of Medicine|January 7, 2011
Iniparib plus chemotherapy in metastatic triple-negative breast cancerJoyce O'Shaughnessy, Cynthia Osborne, John E Pippen, et al.
JCO Precision Oncology|February 1, 2022
Comutation of <i>PIK3CA</i> and <i>TP53</i> in Residual Disease After Preoperative Anti-HER2 Therapy in ERBB2 (HER2)-Amplified Early Breast CancerFrankie Ann Holmes, Maren K Levin, Ying Cao, et al.
Children and Youth Services Review|December 16, 2014
Family Economic Well-Being Following the 1996 Welfare Reform: Trend Data from Five Non-Experimental Panel StudiesKristen Shook Slack, Katherine Magnuson, Lawrence Berger, et al.
American Journal of Obstetrics & Gynecology MFM|June 21, 2022
The transition to parenthood in obstetrics: enhancing prenatal care for 2-generation impactCatherine Monk, Sona Dimidjian, Ellen Galinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2021
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast CancerAditya Bardia, Virginia Kaklamani, Sharon Wilks, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 16, 2015
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studiesHaralambos Raftopoulos, Abderrahmane Laadem, Paul J Hesketh, et al.
JAMA|February 15, 2017
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical TrialJulie Nangia, Tao Wang, Cynthia Osborne, et al.
Breast Cancer Research and Treatment|August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancerJennifer R Diamond, Carlos Becerra, Donald Richards, et al.
Clinical Breast Cancer|August 7, 2017
Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast CancerCynthia Osborne, Jagathi D Challagalla, Charles F Eisenbeis, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Health Affairs (Project Hope)|May 7, 2019
The Culture Of Health In Early Care And Education: Workers' Wages, Health, And Job CharacteristicsJennifer J Otten, Victoria A Bradford, Bert Stover, et al.
The New England Journal of Medicine|January 7, 2011
Iniparib plus chemotherapy in metastatic triple-negative breast cancerJoyce O'Shaughnessy, Cynthia Osborne, John E Pippen, et al.
JCO Precision Oncology|February 1, 2022
Comutation of <i>PIK3CA</i> and <i>TP53</i> in Residual Disease After Preoperative Anti-HER2 Therapy in ERBB2 (HER2)-Amplified Early Breast CancerFrankie Ann Holmes, Maren K Levin, Ying Cao, et al.
Children and Youth Services Review|December 16, 2014
Family Economic Well-Being Following the 1996 Welfare Reform: Trend Data from Five Non-Experimental Panel StudiesKristen Shook Slack, Katherine Magnuson, Lawrence Berger, et al.
American Journal of Obstetrics & Gynecology MFM|June 21, 2022
The transition to parenthood in obstetrics: enhancing prenatal care for 2-generation impactCatherine Monk, Sona Dimidjian, Ellen Galinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2021
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast CancerAditya Bardia, Virginia Kaklamani, Sharon Wilks, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 16, 2015
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studiesHaralambos Raftopoulos, Abderrahmane Laadem, Paul J Hesketh, et al.
JAMA|February 15, 2017
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical TrialJulie Nangia, Tao Wang, Cynthia Osborne, et al.
Breast Cancer Research and Treatment|August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancerJennifer R Diamond, Carlos Becerra, Donald Richards, et al.
Clinical Breast Cancer|August 7, 2017
Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast CancerCynthia Osborne, Jagathi D Challagalla, Charles F Eisenbeis, et al.
Pageof 4